rs55858252

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 1P and 13B. PP2BP4_StrongBP6BS1BS2

The NM_000702.4(ATP1A2):​c.25T>A​(p.Tyr9Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00303 in 1,596,846 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y9C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0021 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0031 ( 9 hom. )

Consequence

ATP1A2
NM_000702.4 missense

Scores

1
2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:14

Conservation

PhyloP100: 1.67

Publications

7 publications found
Variant links:
Genes affected
ATP1A2 (HGNC:800): (ATPase Na+/K+ transporting subunit alpha 2) The protein encoded by this gene belongs to the family of P-type cation transport ATPases, and to the subfamily of Na+/K+ -ATPases. Na+/K+ -ATPase is an integral membrane protein responsible for establishing and maintaining the electrochemical gradients of Na and K ions across the plasma membrane. These gradients are essential for osmoregulation, for sodium-coupled transport of a variety of organic and inorganic molecules, and for electrical excitability of nerve and muscle. This enzyme is composed of two subunits, a large catalytic subunit (alpha) and a smaller glycoprotein subunit (beta). The catalytic subunit of Na+/K+ -ATPase is encoded by multiple genes. This gene encodes an alpha 2 subunit. Mutations in this gene result in familial basilar or hemiplegic migraines, and in a rare syndrome known as alternating hemiplegia of childhood. [provided by RefSeq, Oct 2008]
ATP1A2 Gene-Disease associations (from GenCC):
  • hemiplegic migraine-developmental and epileptic encephalopathy spectrum
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • migraine, familial hemiplegic, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp
  • fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P
  • alternating hemiplegia of childhood 1
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • developmental and epileptic encephalopathy 98
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • alternating hemiplegia of childhood
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

PP2
Missense variant in the ATP1A2 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 63 curated pathogenic missense variants (we use a threshold of 10). The gene has 10 curated benign missense variants. Gene score misZ: 4.7713 (above the threshold of 3.09). Trascript score misZ: 6.824 (above the threshold of 3.09). GenCC associations: The gene is linked to migraine, familial hemiplegic, 2, familial or sporadic hemiplegic migraine, alternating hemiplegia of childhood 1, alternating hemiplegia of childhood, fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies, developmental and epileptic encephalopathy 98, hemiplegic migraine-developmental and epileptic encephalopathy spectrum.
BP4
Computational evidence support a benign effect (MetaRNN=0.012802213).
BP6
Variant 1-160120918-T-A is Benign according to our data. Variant chr1-160120918-T-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 204881.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0021 (319/152130) while in subpopulation NFE AF = 0.00381 (259/68004). AF 95% confidence interval is 0.00343. There are 1 homozygotes in GnomAd4. There are 146 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 9 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000702.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP1A2
NM_000702.4
MANE Select
c.25T>Ap.Tyr9Asn
missense
Exon 2 of 23NP_000693.1P50993

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP1A2
ENST00000361216.8
TSL:1 MANE Select
c.25T>Ap.Tyr9Asn
missense
Exon 2 of 23ENSP00000354490.3P50993
ATP1A2
ENST00000857225.1
c.25T>Ap.Tyr9Asn
missense
Exon 2 of 23ENSP00000527284.1
ATP1A2
ENST00000969831.1
c.25T>Ap.Tyr9Asn
missense
Exon 2 of 23ENSP00000639890.1

Frequencies

GnomAD3 genomes
AF:
0.00210
AC:
319
AN:
152012
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000652
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00138
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000623
Gnomad FIN
AF:
0.0000947
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00381
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00170
AC:
365
AN:
214772
AF XY:
0.00174
show subpopulations
Gnomad AFR exome
AF:
0.000754
Gnomad AMR exome
AF:
0.000948
Gnomad ASJ exome
AF:
0.000106
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000214
Gnomad NFE exome
AF:
0.00314
Gnomad OTH exome
AF:
0.000922
GnomAD4 exome
AF:
0.00313
AC:
4523
AN:
1444716
Hom.:
9
Cov.:
34
AF XY:
0.00305
AC XY:
2191
AN XY:
717300
show subpopulations
African (AFR)
AF:
0.000485
AC:
16
AN:
32996
American (AMR)
AF:
0.000839
AC:
35
AN:
41696
Ashkenazi Jewish (ASJ)
AF:
0.0000387
AC:
1
AN:
25856
East Asian (EAS)
AF:
0.0000260
AC:
1
AN:
38498
South Asian (SAS)
AF:
0.000727
AC:
61
AN:
83914
European-Finnish (FIN)
AF:
0.000172
AC:
9
AN:
52190
Middle Eastern (MID)
AF:
0.000348
AC:
2
AN:
5744
European-Non Finnish (NFE)
AF:
0.00379
AC:
4187
AN:
1104110
Other (OTH)
AF:
0.00353
AC:
211
AN:
59712
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
238
476
715
953
1191
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00210
AC:
319
AN:
152130
Hom.:
1
Cov.:
33
AF XY:
0.00196
AC XY:
146
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.000651
AC:
27
AN:
41504
American (AMR)
AF:
0.00137
AC:
21
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000624
AC:
3
AN:
4810
European-Finnish (FIN)
AF:
0.0000947
AC:
1
AN:
10562
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00381
AC:
259
AN:
68004
Other (OTH)
AF:
0.00284
AC:
6
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
20
39
59
78
98
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00308
Hom.:
0
Bravo
AF:
0.00226
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
4
not provided (5)
-
-
2
Alternating hemiplegia of childhood 1 (2)
-
-
2
Migraine, familial hemiplegic, 2 (2)
-
-
2
not specified (2)
-
-
1
Developmental and epileptic encephalopathy 98 (1)
-
-
1
Familial hemiplegic migraine (1)
-
-
1
Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.12
CADD
Uncertain
23
DANN
Benign
0.94
DEOGEN2
Benign
0.23
T
Eigen
Benign
-0.21
Eigen_PC
Benign
-0.028
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.90
D
M_CAP
Benign
0.084
D
MetaRNN
Benign
0.013
T
MetaSVM
Benign
-0.69
T
MutationAssessor
Benign
1.1
L
PhyloP100
1.7
PrimateAI
Uncertain
0.74
T
PROVEAN
Benign
0.20
N
REVEL
Benign
0.28
Sift
Benign
0.34
T
Sift4G
Benign
0.24
T
Varity_R
0.12
gMVP
0.79
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs55858252; hg19: chr1-160090708; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.